European Medicines Agency to Move to Amsterdam

A coin toss decides the agency’s post-Brexit home once it departs from London.

Written byShawna Williams
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

AmsterdamISTOCK, KARP85The European Medicines Agency (EMA), an organization that regulates drugs sold in the European Union for human and animal use, determined today (November 20) it will move from London to Amsterdam. The agency, which EU Observer reports employs 890 people, is making the move because of Britain’s decision to leave the E.U. in 2019. It has been based in London since 1995, the BBC reports.

Cities across Europe bid to be the new site for the EMA, which “promises to make its new host into a hub for Europe's medical industry,” the BBC notes. After three rounds of voting among EU ministers, Milan and Amsterdam were tied for the most votes, so the winner was decided by a coin toss. A vote on the new location for the European Banking Agency, also headquartered in London, is expected later today.

“The relocation of the E.M.A. away from London will be a bitter pill to swallow,” says Rory Palmer, a spokesperson for the UK Labour Party’s lawmakers in the European Parliament, in a statement to the New York Times. “Our economy will suffer. Our health sector will suffer. Our successful pharmaceutical industry ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor’s degree in biochemistry from Colorado College and a graduate certificate in science communication from the University of California, Santa Cruz. Previously, she worked as a freelance editor and writer, and in the communications offices of several academic research institutions. As news director, Shawna assigned and edited news, opinion, and in-depth feature articles for the website on all aspects of the life sciences. She is based in central Washington State, and is a member of the Northwest Science Writers Association and the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies